Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Metabolomics. 2015 Feb 13;11(5):1287–1301. doi: 10.1007/s11306-015-0786-7

Fig. 3.

Fig. 3

Unsupervised heat maps of all identified metabolites and their associated fold changes in Brg1/Brm double-mutant hearts compared to a Control Group 1 (Brg1floxed/floxed; αMHC-Cre-ERT+/0; Brm−/− minus tamoxifen treatment), b Control Group 2 (Brg1floxed/floxed; αMHC-Cre-ERT0/0(no transgene); Brm−/− mice plus tamoxifen treatment), and c Combined Groups 1 & 2 controls. d Identification of the VIP significant metabolites (p<0.05). N = 8 (Brg1/Brm double mutant hearts), N = 3 (Control Group 1), N = 3 (Control Group 2), N = 6 (Control Groups 1 & 2) hearts per group analyzed